AIMS/HYPOTHESIS: The aim of this study was to compare the magnitude of the effect of diabetes and stroke at baseline and during follow-up on risk of stroke mortality. MATERIALS AND METHODS: Study cohorts included 25,155 Finnish men and 26,423 women aged 25-74 years. Data on diabetes and stroke history at baseline, their incidence during follow-up, and stroke death were obtained from national registers. RESULTS: During a mean follow-up of 18.9 years, 838 stroke deaths were recorded. In the baseline study, hazard ratios (HRs) for stroke mortality were 5.26 for men with prior diabetes only, 4.76 for men with prior stroke only, and 13.4 for men with both prior diabetes and stroke compared with men without diabetes and stroke at baseline and during follow-up. In women, the corresponding hazard ratios were 7.29, 5.27 and 5.52, respectively. When only diabetes and stroke status during the follow-up were considered, the hazard ratios for stroke mortality were 1.41 for men and 1.56 for women with incident diabetes only, 5.62 for men and 5.58 for women with incident stroke only, and 5.59 for men and 4.48 for women with both incident diabetes and stroke compared with men and women without diabetes and stroke at baseline and during follow-up. CONCLUSIONS/ INTERPRETATION: Diabetes and stroke, present either at baseline or during follow-up, markedly increase the risk of stroke death. Prior stroke at baseline carries a similar risk of stroke mortality as prior diabetes. There is a greater risk of stroke mortality associated with incident stroke during follow-up than with incident diabetes.
AIMS/HYPOTHESIS: The aim of this study was to compare the magnitude of the effect of diabetes and stroke at baseline and during follow-up on risk of stroke mortality. MATERIALS AND METHODS: Study cohorts included 25,155 Finnish men and 26,423 women aged 25-74 years. Data on diabetes and stroke history at baseline, their incidence during follow-up, and stroke death were obtained from national registers. RESULTS: During a mean follow-up of 18.9 years, 838 stroke deaths were recorded. In the baseline study, hazard ratios (HRs) for stroke mortality were 5.26 for men with prior diabetes only, 4.76 for men with prior stroke only, and 13.4 for men with both prior diabetes and stroke compared with men without diabetes and stroke at baseline and during follow-up. In women, the corresponding hazard ratios were 7.29, 5.27 and 5.52, respectively. When only diabetes and stroke status during the follow-up were considered, the hazard ratios for stroke mortality were 1.41 for men and 1.56 for women with incident diabetes only, 5.62 for men and 5.58 for women with incident stroke only, and 5.59 for men and 4.48 for women with both incident diabetes and stroke compared with men and women without diabetes and stroke at baseline and during follow-up. CONCLUSIONS/ INTERPRETATION:Diabetes and stroke, present either at baseline or during follow-up, markedly increase the risk of stroke death. Prior stroke at baseline carries a similar risk of stroke mortality as prior diabetes. There is a greater risk of stroke mortality associated with incident stroke during follow-up than with incident diabetes.
Authors: Gang Hu; Pekka Jousilahti; Qing Qiao; Markku Peltonen; Shuichi Katoh; Jaakko Tuomilehto Journal: J Am Coll Cardiol Date: 2005-05-03 Impact factor: 24.094
Authors: M Mähönen; V Salomaa; I Keskimäki; V Moltchanov; J Torppa; A Molarius; J Tuomilehto; C Sarti Journal: Eur J Epidemiol Date: 2000 Impact factor: 8.082
Authors: Anthony Keech; David Colquhoun; James Best; Adrienne Kirby; R John Simes; David Hunt; Wendy Hague; Elaine Beller; Manjula Arulchelvam; Jennifer Baker; Andrew Tonkin Journal: Diabetes Care Date: 2003-10 Impact factor: 19.112
Authors: Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller Journal: Lancet Date: 2004 Aug 21-27 Impact factor: 79.321
Authors: Wenhui Zhao; Peter T Katzmarzyk; Ronald Horswell; Yujie Wang; Jolene Johnson; Gang Hu Journal: Diabetologia Date: 2014-02-28 Impact factor: 10.122
Authors: Ana López-de-Andrés; Rodrigo Jimenez-Garcia; Valentin Hernández-Barrera; Isabel Jiménez-Trujillo; José J Zamorano-León; David Carabantes-Alarcon; Marta Lopez-Herranz; José M de Miguel-Yanes; Javier de Miguel-Diez Journal: Int J Environ Res Public Health Date: 2021-04-01 Impact factor: 3.390
Authors: Gertrude Namale; Onesmus Kamacooko; Alison Kinengyere; Laetitia Yperzeele; Patrick Cras; Edward Ddumba; Janet Seeley; Robert Newton Journal: J Trop Med Date: 2018-05-31
Authors: Weronika A Szlachetka; Tiberiu A Pana; Somsak Tiamkao; Allan B Clark; Kannikar Kongbunkiat; Kittisak Sawanyawisuth; Joao H Bettencourt-Silva; Narongrit Kasemap; Mamas A Mamas; Phyo K Myint Journal: Glob Heart Date: 2020-02-06
Authors: Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; José M de Miguel-Yanes; David Carabantes-Alarcon; Javier de Miguel-Diez; Marta Lopez-Herranz Journal: Cardiovasc Diabetol Date: 2021-07-09 Impact factor: 9.951